Kambourov & Partners is sought out by a range of clients in the healthcare and life sciences sector, including pharmaceutical companies, healthcare providers and medical device manufacturers. The practice handles the full spectrum of mandates across the sector, including intellectual property rights, corporate transactions and dispute resolution. Ivo Alexandrov has in-depth knowledge of regulatory and compliance matters in the pharmaceutical, biotechnology, clinical research, and healthcare industries, and leads the team with Andrey Alexandrov who advises on employment and data protection matters.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Sector knowledge
Testimonials
Collated independently by Legal 500 research team.
- 'I’d particularly like to highlight Zlatko Grigorov, whose support and insight were indispensable. He handled complex issues with skill and dedication, often going above and beyond to move things forward efficiently.'
- 'The team is made up of exceptionally bright and capable lawyers who are a pleasure to work with. They’ve always been professional yet practical, offering advice that truly fits the business context. I value their flexibility and how quickly they respond without compromising quality. Their broad expertise means I can rely on them for a range of matters, and their efficiency and pragmatic approach set them apart from other firms I’ve worked with.'
- 'The individuals I’ve worked with have been consistently proactive and deeply engaged in every matter. They don’t just respond to questions - they take the initiative to understand the context and dive into the details, ensuring nothing is overlooked. Their availability and commitment have been exceptional.'
- 'Collaborative and innovative.'
- 'Client-focused and commercially switched on.'
Key clients
- Bolt Operations OÜ
- Vittoria Pharma
- AXIS Dental Bulgaria
- VIDAS Drinks
- Dentatechnica
- Sarepta Therapeutics
- Intermedica
- Arlington Capital Partners
- Herbalife
- Dentstore Bulgaria
- Samex LLC
Work highlights
Advised Sarepta Therapeutics on the regulatory framework for supplying unauthorised medicinal products under Bulgaria’s named patient program (NPP), including post-trial access, compliance with promotional activity rules, and pricing issues under national and EU laws.
Advised Bolt Operations OÜ on the full regulatory compliance strategy for launching its food delivery platform in Bulgaria, including food safety licensing, traceability, consumer protection, and registration before the Bulgarian Food Safety Agency (BFSA).
Advised Arlington Capital Partners on the Bulgarian legal aspects of its acquisition of August Research, a regional contract research organisation (CRO).
Practice head
Ivo Alexandrov; Andrey Alexandrov
Other key lawyers
Zlatko Grigorov